Filter

611 - 620 of 795 Results

  • Public Views on Direct-to-Consumer Prescription Drug Advertising

    Poll Finding

    Mollyann Brodie, Kaiser vice president and director of Public Opinion and Media Research, testified before the House Energy and Commerce Subcommittee on Oversight and Investigations about the public's views of prescription drugs, the pharmaceutical industry, and direct-to-consumer drug advertising. Brodie's testimony was a part of the hearing titled, "Direct-to-Consumer Advertising: Marketing, Education, or Deception?" Testimony (.pdf)

  • Study Finds Advertising By Insurers Favors Medicare Advantage Over Stand-Alone Drug Plans

    Issue Brief

    As the marketing period for 2009 Medicare plans nears, the Kaiser Family Foundation Kaiser Family Foundation issued a report analyzing the content and frequency of television, print and radio advertisement for private Medicare plans that ran nationally or in one of three local media markets (Miami/Fort Lauderdale, Fla.; Phoenix, Ariz.; and Greensboro, N.C) during the marketing and enrollment period for 2008 plan offerings. The study finds that insurers last year placed three times more advertisements…

  • Medicare Part D 2011 Data Spotlights

    Report

    The Kaiser Family Foundation has issued a collection of analyses related to the Medicare Part D stand-alone drug plan options available to seniors for calendar year 2011. These spotlights focuses on key aspects of the drug plan choices available and relevant trends since the Medicare drug benefit took effect in 2006. They were prepared by a team of researchers at Georgetown University, NORC and the Kaiser Family Foundation. 2012 Part D Data Spotlights Now Available…

  • Selected Findings on the New Medicare Rx Drug Law – Chartpack

    Poll Finding

    Selected Survey Findings on the New Medicare Rx Drug Law - Chartpack Seniors are confused about the Medicare prescription drug law. Below is a series of chart illustrating selected findings from the January/February 2004 Kaiser Health Poll Report survey. The findings show that while about two-thirds of seniors report following the debate closely, just 15% say they understand the new prescription drug law very well and seven in 10 don’t know that it passed and…

  • The New Medicare Drug Benefit:  Potential Effects of Pharmacy Management Tools on Access to Medications

    Issue Brief

    The New Medicare Drug Benefit: Potential Effects of Pharmacy Management Tools on Access to Medications This report describes the pharmacy benefit management tools that will be available to private plans administering the new Medicare drug benefit, including formularies, the definition of categories and classes, and cost sharing requirements. The authors conclude that substantial flexibility given to plans to design management tools could have significant implications for beneficiaries’ access to needed medications and out-of-pocket spending. Issue…

  • Medicare Part D Prescription Drug Plan Availability in 2013

    Fact Sheet

    This fact sheet contains 2013 state-specific summary data about available Medicare drug benefit options, including premium ranges and the number of plans available at no cost to qualifying beneficiaries. Fact Sheet (.pdf)

  • The Growth of Private Plans in Medicare, 2006

    Issue Brief

    , details the different types of private plan options available to people on Medicare. These include Medicare Advantage plans (such as Medicare HMOs, PPOs and private fee-for-service plans) and new stand-alone prescription drug plans. • In 2006, all Medicare beneficiaries have access to at least one type of private Medicare Advantage plan, up from 77% in 2004. The increase in access stems largely from the creation of new Medicare regional PPOs and the expansion of…